Jianying Zhou
26PUBLICATIONS
82CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (26)
Sort by Publication Date:
|Feb 25, 2026
Prospective Observational Real-World Study of Afatinib as First-Line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in China.Jianying Zhou, Yongsheng Wang, Jiewen Peng
|Aug 02, 2025
The Association Between Thromboembolic Events and ALK, ROS1, RET Rearrangements or EGFR Mutations in Patients With Advanced Lung Adenocarcinoma: A Retrospective Cohort Study.Xiaohan Qian, Mengjiao Fu, Jing Zheng
|May 28, 2024
Value Evaluation of Quantitative Aspergillus fumigatus-Specific IgG Antibody Test in the Diagnosis of Non-neutropenic Invasive Pulmonary Aspergillosis.Lingyan Sheng, Wenhong Jiang, Yake Yao
|Jul 14, 2023
HLA-I Evolutionary Divergence Confers Response to PD-1 Blockade plus Chemotherapy in Untreated Advanced Non-Small Cell Lung Cancer.Tao Jiang, Qiqi Jin, Jiahao Wang
|Jun 05, 2023
SETD4 Confers Cancer Stem Cell Chemoresistance in Nonsmall Cell Lung Cancer Patients via the Epigenetic Regulation of Cellular Quiescence.Yuehong Wang, Yuman Yu, Weijun Yang
|Mar 27, 2023
Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis.Chong Kin Liam, Azura Rozila Ahmad, Te-Chun Hsia
Pageof 5
